DrugRisk Update: Court Holds NuvaRing Claims For Settlement Talks

The DrugRisk Center is the Web’s largest source for information on prescription drug warnings, side effects and legal news. Visit http://www.DrugRisk.com

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
Due to the number of women who have filed a NuvaRing lawsuit alleging blood clots from the device, many cases have been consolidated to a special federal multidistrict litigation NuvaRing court.

New York, NY (PRWEB) February 06, 2014

The birth control safety center DrugRisk.com has added additional legal news for women who have used the contraceptive NuvaRing. Lawsuits alleging the device caused blood clots have been placed on hold by a federal court so that parties can try to reach a settlement*.

DrugRisk is a free resource center for those who use popular prescription drugs or medical devices. By sharing the latest news, safety alerts, product recalls and litigation updates, patients can avoid dangerous products. Visitors can also see if others are experiencing similar side effects and decide if they need legal advice.

NuvaRing is a small plastic vaginal ring contraceptive approved by the FDA in 2001. Today it is marketed in over 50 countries and used by an estimated 1.5 million women worldwide**.

DrugRisk has added warnings from health experts like the New England Journal of Medicine showing vaginal ring contraceptives like NuvaRing may have 6.5 times the risk of blood clots over non-hormonal methods***.

Due to the number of women who have filed a NuvaRing lawsuit alleging blood clots from the device, many cases have been consolidated to a special federal multidistrict litigation NuvaRing court. The formal case is In re: NuvaRing Products Liability Litigation, No. 08-md-1964, JPML, Eastern District Missouri.

Recent court records obtained by DrugRisk show 1,658 NuvaRing claims have been filed as of January 15****.

Now, the resource center has learned that Judge Sippel, who oversees the litigation, postponed the first trial and has placed legal action on hold through May 31, in order to give parties additional time to work on a settlement.*

Anyone who suffered a blood clot, stroke, DVT or pulmonary embolism after using NuvaRing is urged to visit DrugRisk or speak with a lawyer about their legal rights as soon as possible. DrugRisk only recommends lawyers who have already handled NuvaRing lawsuits.

For more information on the research, side effects and litigation news related to NuvaRing and other drugs, or to speak with a lawyer, visit http://www.DrugRisk.com.

*Judge Rodney Sippel, 1/9/14; aboutlawsuits.com/wp-content/uploads/2014-01-09-NuvaRing-Trial-Order.pdf; aboutlawsuits.com/wp-content/uploads/2013-01-09-NuvaRing-Stay.pdf
**Huffington Post, 12/18/13; huffingtonpost.com/2013/12/18/nuvaring-blood-clots_n_4461429.html
***New England Journal of Medicine, 6/14/12; nejm.org/doi/full/10.1056/NEJMoa1111840
****Judicial Panel on Multidistrict Litigation, 1/15/14; jpml.uscourts.gov/sites/jpml/files/Pending_MDL_Dockets_By_District-January-15-2014.pdf


Contact